Omeros Corp Sustainability Reports
Omeros Corporation is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes small-molecule and protein therapeutics. Its pipeline primarily focuses on large-market and orphan indications targeting immunologic and complement-mediated diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300CJWLXX2MXVVV71
FIGI: BBG001SPJH21
10 reports from 2010 to 2024
